The Act on the Safety of and Support for Advanced Regenerative Medicine and Advanced Biological Products came in force in August 2020. RMAF was established to efficiently and systematically promote the ARM projects through the establishment of a public-private ownership to realize and facilitate the intent and objectives of the legislation.